SCHEMBL21363680

SCHEMBL21363680

CC(C)(C)c1cc2c(cc1OCCCl)OCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.41
MAOB P27338 3/20 0.35
LMNA P02545 4/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 2/20 0.33
MAPK1 P28482 2/20 0.33
IGF1R P08069 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KMT2A Q03164 1/20 0.33
KCNH2 Q12809 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
KDM4E B2RXH2 3/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363676 0.82 SLC6A9 (0.45) SLC6A9MAOBLMNAHPGDHTT
SCHEMBL21363674 0.74 CDK4 (0.44) SLC6A9MAOBLMNAHTTL3MBTL1
SCHEMBL6364660 0.73 CYP3A4 (0.39) LMNAHPGDMAPK1KDM4ESMN1; SMN2
SCHEMBL21363667 0.73 SLC6A9 (0.36) SLC6A9LMNAHPGDIGF1RKMT2A
SCHEMBL21363675 0.71 CYP3A4 (0.44) MAOBKMT2AKDM4ESMN1; SMN2ALOX15
SCHEMBL21366553 0.70 SLC6A9 (0.32) SLC6A9LMNAHPGDGAA
SCHEMBL11085807 0.69 RAB9A (0.42) SLC6A9MAOBLMNAMAPK1L3MBTL1
SCHEMBL12203329 0.69 PTGS2 (0.37) MAOBLMNAHPGDL3MBTL1KMT2A
SCHEMBL11086473 0.68 MAOB (0.42) MAOBLMNAHPGDKMT2AKDM4E
SCHEMBL24008355 0.67 ALDH1A1 (0.40) LMNAHPGDMAPK1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed